OA07103A - Nouvelles 1,2-diaminocyclobutène-3,4-diones, leur procédé de préparation et composition pharmaceutique les contenant. - Google Patents

Nouvelles 1,2-diaminocyclobutène-3,4-diones, leur procédé de préparation et composition pharmaceutique les contenant.

Info

Publication number
OA07103A
OA07103A OA57692A OA57692A OA07103A OA 07103 A OA07103 A OA 07103A OA 57692 A OA57692 A OA 57692A OA 57692 A OA57692 A OA 57692A OA 07103 A OA07103 A OA 07103A
Authority
OA
OAPI
Prior art keywords
diaminocyclobutene
diones
new
pharmaceutical composition
composition containing
Prior art date
Application number
OA57692A
Other languages
English (en)
Inventor
Aldo Anntonio Algieri
Ronnie Ray Crenshaw
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of OA07103A publication Critical patent/OA07103A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/46Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/64One oxygen atom attached in position 2 or 6
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
OA57692A 1981-05-18 1982-05-18 Nouvelles 1,2-diaminocyclobutène-3,4-diones, leur procédé de préparation et composition pharmaceutique les contenant. OA07103A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/264,533 US4390701A (en) 1981-05-18 1981-05-18 1-Amino-2-[3-(3-piperidinomethylphenoxy)propylamino]cyclobutene-3,4-dione

Publications (1)

Publication Number Publication Date
OA07103A true OA07103A (fr) 1987-01-31

Family

ID=23006472

Family Applications (1)

Application Number Title Priority Date Filing Date
OA57692A OA07103A (fr) 1981-05-18 1982-05-18 Nouvelles 1,2-diaminocyclobutène-3,4-diones, leur procédé de préparation et composition pharmaceutique les contenant.

Country Status (37)

Country Link
US (1) US4390701A (fr)
JP (2) JPS57193427A (fr)
KR (1) KR880000968B1 (fr)
AT (1) AT384805B (fr)
AU (1) AU541843B2 (fr)
BE (1) BE893236A (fr)
CA (1) CA1190224A (fr)
CH (2) CH649527A5 (fr)
CS (1) CS244423B2 (fr)
CY (1) CY1446A (fr)
DD (1) DD202426A5 (fr)
DE (2) DE3218584A1 (fr)
DK (1) DK159146C (fr)
ES (1) ES8306709A1 (fr)
FI (1) FI78695C (fr)
FR (2) FR2505835B1 (fr)
GB (1) GB2098988B (fr)
GR (1) GR75493B (fr)
HK (2) HK83288A (fr)
HU (2) HUT38613A (fr)
IE (1) IE53274B1 (fr)
IL (1) IL65803A (fr)
IT (1) IT1210686B (fr)
KE (1) KE3829A (fr)
LU (1) LU84157A1 (fr)
MY (1) MY8800118A (fr)
NL (1) NL189405C (fr)
NO (1) NO158419C (fr)
NZ (1) NZ200586A (fr)
OA (1) OA07103A (fr)
PT (1) PT74923B (fr)
SE (1) SE457081B (fr)
SG (1) SG38388G (fr)
SU (1) SU1375127A3 (fr)
YU (2) YU43077B (fr)
ZA (1) ZA823328B (fr)
ZW (1) ZW9782A1 (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR228941A1 (es) * 1978-04-26 1983-05-13 Glaxo Group Ltd Procedimiento para preparar nuevos derivados de 3,5-diamino-1,2,4-triazol que son activos contra receptores histaminicos
US4788184A (en) * 1981-05-18 1988-11-29 Bristol-Myers Company Substituted 3-cyclobutene-1,2-diones as anti-ulcer agents
US4847264A (en) * 1982-07-21 1989-07-11 Rorer Pharmaceutical Corporation Bicyclic nitrogen heterocyclic ethers and thioethers, and their pharmaceutical uses
US4466970A (en) * 1982-10-02 1984-08-21 Smith Kline & French Laboratories Limited Dioxocyclobutene compounds
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives
US4588719A (en) * 1984-04-27 1986-05-13 William H. Rorer, Inc. Bicyclic benzenoid aminoalkylene ethers and thioethers, pharmaceutical compositions and use
DE3326545A1 (de) * 1983-07-22 1985-01-31 Ludwig Heumann & Co GmbH, 8500 Nürnberg Propan-2-ol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3404786A1 (de) * 1984-02-10 1985-08-14 Ludwig Heumann & Co GmbH, 8500 Nürnberg Neue alkanolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltendes arzneimittel
DE3408327A1 (de) * 1984-03-07 1985-09-12 Ludwig Heumann & Co GmbH, 8500 Nürnberg Diaminderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
JPS60255756A (ja) * 1984-06-01 1985-12-17 Ikeda Mohandou:Kk アミノアルキルフエノキシ誘導体
FR2571723B1 (fr) * 1984-10-12 1988-08-26 Lipha Derives de thieno et furo-(2,3-c) pyrroles, procedes de preparation et medicaments les contenant
US4785003A (en) * 1984-10-16 1988-11-15 Biomeasure, Inc. N-disubstituted glycine and B-amino-propionic acid derivatives having anti-ulcer activity
US4598067A (en) * 1984-10-16 1986-07-01 Biomeasure, Inc. Antiulcer compounds
US4595757A (en) * 1984-12-13 1986-06-17 American Home Products Corporation N-alkylated benzo- and hetero-fused antisecretory agents
DE3568374D1 (en) * 1985-12-20 1989-03-30 Litef Gmbh Method to determine heading by using and automatically calibrating a 3-axis magnetometer rigidly fitted in an aircraft
US4927970A (en) * 1987-05-14 1990-05-22 Bristol-Myers Company Substituted 3-cyclobutene-1,2-dione intermediates
US4927968A (en) * 1987-05-14 1990-05-22 Bristol-Myers Company Chemical intermediates and process
US5112866A (en) * 1988-09-06 1992-05-12 Ortho Pharmaceutical Corporation Ethanesulfonamide derivatives
US5168103A (en) * 1991-01-22 1992-12-01 American Home Products Corporation [[2-(amino-3,4-dioxo-1-cyclobuten-1-yl) amino]alkyl]-acid derivatives
WO1994020489A1 (fr) * 1993-03-09 1994-09-15 Sankyo Company, Limited Derive de thienylobutenyle
US5354763A (en) * 1993-11-17 1994-10-11 American Home Products Corporation Substituted N-heteroaryl and N-aryl-1,2-diaminocyclobutene-3,4-diones
US5506252A (en) * 1993-11-17 1996-04-09 American Home Products Corporation Substituted N-heteroaryl and N-aryl-1,2-diaminocyclobutene-3,4-diones
US5466712A (en) * 1994-11-04 1995-11-14 American Home Products Corporation Substituted n-aryl-1,2-diaminocyclobutene-3,4-diones
US5464867A (en) * 1994-11-16 1995-11-07 American Home Products Corporation Diaminocyclobutene-3,4-diones
US5872139A (en) * 1996-06-17 1999-02-16 American Home Products Corporation Heterocyclymethylamino derivatives of cyclobutene-3,4-diones
US5846999A (en) * 1996-07-17 1998-12-08 American Home Products Corporation Substituted N-arylmethylamino derivatives of cyclobutene-3,4-diones
US5763474A (en) * 1996-07-17 1998-06-09 American Home Products Corporation Substituted N-arylmethylamino derivatives of cyclobutene-3,4-diones
US5750574A (en) * 1996-07-17 1998-05-12 American Home Products Corporation Fluorinated N-arylmethylamino derivatives of cyclobutene-3,4-diones
US5780505A (en) * 1996-07-17 1998-07-14 American Home Products Corporation Substituted N-arylmethylamino derivatives of cyclobutene-3, 4-diones
US5840764A (en) * 1997-01-30 1998-11-24 American Home Products Corporation Substituted hydroxy-anilino derivatives of cyclobutene-3,4-diones
US6376555B1 (en) 1998-12-04 2002-04-23 American Home Products Corporation 4-substituted-3-substituted-amino-cyclobut-3-ene-1,2-diones and analogs thereof as novel potassium channel openers
TW200514775A (en) * 2003-10-22 2005-05-01 Wyeth Corp Methods for the preparation of {2-[(8,9)-dioxo-2,6-diaza-bicyclo[5.2.0]-non-1(7)-en-2-yl]ethyl} phosphonic acid and esters thereof
CN103242210B (zh) * 2012-02-09 2014-09-24 北京艾百诺科技有限公司 含有取代方酸的乙酸妙林酯及其应用
WO2022034121A1 (fr) 2020-08-11 2022-02-17 Université De Strasbourg Bloqueurs de h2 ciblant des macrophages du foie pour la prévention et le traitement d'une maladie du foie et du cancer
JP7577981B2 (ja) * 2020-11-27 2024-11-06 セイコーエプソン株式会社 可塑化装置、射出成形装置および三次元造形装置

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3346583A (en) * 1967-10-10 Disubstituted-a-phenethylamines
GB1563090A (en) * 1975-07-31 1980-03-19 Smith Kline French Lab Cyclobutene-diones
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
GB2001624B (en) 1977-04-20 1982-03-03 Ici Ltd Guanidine derivatives processes for their manufacture and pharmaceutical compositions containing them
GB1604674A (en) * 1977-05-17 1981-12-16 Allen & Hanburys Ltd Aminoalkyl-benzene derivatives
GB1601459A (en) * 1977-05-17 1981-10-28 Allen & Hanburys Ltd Aminoalkyl thiophene derivatives
GB2023133B (en) 1978-04-26 1982-09-08 Glaxo Group Ltd Heterocyclic derivatives
ATE1353T1 (de) * 1978-05-24 1982-08-15 Imperial Chemical Industries Plc Anti-sekretion thiadiazol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
US4242351A (en) * 1979-05-07 1980-12-30 Imperial Chemical Industries Limited Antisecretory oxadiazoles and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
NO158419B (no) 1988-05-30
FR2505835A1 (fr) 1982-11-19
SG38388G (en) 1989-01-27
IE821169L (en) 1982-11-18
FR2513250B1 (fr) 1986-03-07
CY1446A (en) 1989-03-10
CH649527A5 (de) 1985-05-31
CA1190224A (fr) 1985-07-09
GB2098988B (en) 1985-07-24
IE53274B1 (en) 1988-09-28
AU8362082A (en) 1982-11-25
JPH0251425B2 (fr) 1990-11-07
KR830009773A (ko) 1983-12-23
DK159146B (da) 1990-09-10
FI78695B (fi) 1989-05-31
YU43077B (en) 1989-02-28
FR2513250A1 (fr) 1983-03-25
KR880000968B1 (ko) 1988-06-07
FI78695C (fi) 1989-09-11
AU541843B2 (en) 1985-01-24
PT74923A (en) 1982-06-01
NZ200586A (en) 1985-09-13
NO821586L (no) 1982-11-19
CS244423B2 (en) 1986-07-17
YU104382A (en) 1985-04-30
SE457081B (sv) 1988-11-28
JPH0478628B2 (fr) 1992-12-11
JPS57193427A (en) 1982-11-27
GB2098988A (en) 1982-12-01
JPH0236159A (ja) 1990-02-06
DK219382A (da) 1982-11-19
YU212784A (en) 1985-08-31
US4390701A (en) 1983-06-28
ZW9782A1 (en) 1982-12-15
GR75493B (fr) 1984-07-24
SE8203092L (sv) 1982-11-19
ATA197282A (de) 1987-06-15
NO158419C (no) 1988-09-07
MY8800118A (en) 1988-12-31
DE3218584A1 (de) 1982-12-23
NL8201999A (nl) 1982-12-16
PT74923B (en) 1986-11-13
FI821698A0 (fi) 1982-05-13
DK159146C (da) 1991-02-18
DE3249715C2 (fr) 1991-07-11
CH653989A5 (de) 1986-01-31
IL65803A0 (en) 1982-08-31
HK83288A (en) 1988-10-21
FR2505835B1 (fr) 1985-11-15
AT384805B (de) 1988-01-11
IT8248435A0 (it) 1982-05-17
LU84157A1 (fr) 1983-04-13
HU194802B (en) 1988-03-28
ES512279A0 (es) 1983-06-01
ES8306709A1 (es) 1983-06-01
HUT38613A (en) 1986-06-30
DE3218584C2 (fr) 1989-11-02
HK84688A (en) 1988-10-28
ZA823328B (en) 1983-03-30
IT1210686B (it) 1989-09-20
IL65803A (en) 1988-02-29
DD202426A5 (de) 1983-09-14
NL189405C (nl) 1993-04-01
BE893236A (fr) 1982-11-18
SU1375127A3 (ru) 1988-02-15
KE3829A (en) 1988-12-02

Similar Documents

Publication Publication Date Title
OA07103A (fr) Nouvelles 1,2-diaminocyclobutène-3,4-diones, leur procédé de préparation et composition pharmaceutique les contenant.
FR2518095B1 (fr) Nouveaux l-oxa-, thia- et aza-spirocyclo-benzene-acetamides et benzamides, leur procede de preparation et composition pharmaceutique les contenant
OA07282A (fr) Composition pharmaceutique lyophilisée contenant de l'interféron procédé pour la préparation et procédé pour sa stabilisation.
FR2567131B1 (fr) Nouveaux derives de ganglioside, procede pour leur obtention et composition pharmaceutique les contenant
OA08647A (fr) Dérivés d'imidazole, procédés pour leur préparation et composition pharmaceutique les contenant.
BE890574A (fr) Derive d'aminoalcoyl-furanne, procede pour sa preparation et composition pharmaceutique le contenant
OA07172A (fr) Nouvelles thiazolidinediones, leur procédé de production et préparation pharmaceutique les contenant.
OA08462A (fr) Composés hétérocycliques condensés azotés, procédés pour les séparer et composition pharmaceutique en contenant.
FR2495154B1 (fr) 5'-aminoalkyl-4', 4, 8-trialkylpsoralenes, leur procede de production et composition pharmaceutique les contenant
BE880584A (fr) Nouveaux derives d'imidazole, leur procede de production et composition pharmaceutique les contenant
OA07354A (fr) Nouveaux dérivés de céphalosporine, leur procédé de production et composition pharmaceutique les contenant.
BE861964A (fr) Derives de la 1,4-dihydropyridine, leur procede d'obtention et composition pharmaceutique les contenant
BE893378A (fr) Derives de carboximide, procedes pour leur preparation et medicament les contenant
FR2569702B1 (fr) Nouvelle 4'-deschlororebeccamycine, composition pharmaceutique la contenant et procede pour sa preparation
FR2567519B1 (fr) Nouvelles isoindolinyl-alcoyl-piperazines, compositions pharmaceutiques les contenant, et leur procede de preparation
BE892552A (fr) Nouveaux amido-aminoacides, compositions pharmaceutiques les contenant et procede de preparation de ces amido-aminoacides
OA07585A (fr) Nouveaux composés hétérocycliques, leur procédé de préparation et composition pharmaceutique les contenant.
BE878230A (fr) Nouveaux derives d'imidazole, leur procede de production et composition pharmaceutique les contenant
OA07341A (fr) Nouveaux oximéthers, procédé pour leur préparation, agents contenant les nouveaux oximéthers et leur application.
FR2303559A1 (fr) Nouveaux derives d'histidine, leur procede de preparation et composition pharmaceutique les contenant
OA07171A (fr) Spirothiazolidineone, son procédé de préparation et préparation pharmaceutique la contenant.
FR2528425B1 (fr) 1,4-dihydropyridines et composition pharmaceutique les contenant
FR2601951B1 (fr) Nouvelles tetrahydrocarbazolones, composition pharmaceutique les contenant et leur procede de preparation
FR2503713B1 (fr) 2,3-di-substitue-5,6-dihydro-imidazo-(2,1-b) thiazoles, procede pour leur preparation et agents anti-inflammatoires les contenant
FR2704857B1 (fr) Nouvelles benzodioxines substituées, leur procédé de préparation et les compositions pharmaceutiques les contenant.